CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin.

As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own ...

The new year will begin with some first-of-their-kind laws in several states. Hawaii will become the first state to raise its ...

California’s health care landscape today would probably disappoint the Gavin Newsom who spent much of 2017 and 2018 campaigning to become governor.

Eli Lilly on Thursday revealed new data that could help it catch rival Novo Nordisk in a race between the two large drugmakers to develop a once-weekly insulin shot. The Indianapolis-based drugmaker ...